Larvol Delta - Benitec-Biopharma-Reports-Positive-Interim-Clinical-Results-for-Three-Subjects-Treated-with-BB301-in-Phase-1b2a-Study-to-be-Presented-at-the-2025-Muscular-Dystrophy-Association-Clinical-amp-Scientic-Conference

Pabparna (BB-301) - Benitec BioPharma

https://www.globenewswire.com/news-release/2025/03/19/3045233/0/en/Benitec-Biopharma-Reports-Positive-Interim-Clinical-Results-for-Three-Subjects-Treated-with-BB-301-in-Phase-1b-2a-Study-to-be-Presented-at-the-2025-Muscular-Dystrophy-Association-C.html

Mar 19, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next